Plasminogen activator inhibitor (PAI)-1 overexpression in retinal microvessels of PAI-1 transgenic mice

Maria B. Grant, Polyxenie E. Spoerri, Denifield W. Player, David M. Bush, E. Ann Ellis, Sergio Caballero, W. Gerald Robison

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

PURPOSE. Previous studies have suggested that disturbances in plasminogen activator inhibitor (PAI)-1 may be relevant to the development of diabetic microvascular complications. To determine whether overexpression of PAI-1 in cells of retinal microvasculature would result in a disease similar to that observed in diabetes, ocular tissue from transgenic mice that overexpress human PAI-1 were examined. METHODS. Transgenic mice were administered ZnSO4 (25 mM) in their water for up to 49 weeks to activate the metallothionein promoter and stimulate human PAI-1. Colloidal gold immunocytochemistry was used to quantify the human PAI-1 antigen at 7, 20, 34, and 49 weeks of ZnSO4 administration. Cross sections of retinal microvessels were examined by electron microscopy for changes in basement membrane (BM) thickness. Retinal digest preparations were examined by light microscopy for possible microangiopathy, including changes in endothelial cell-to-pericyte ratios. RESULTS. Human PAI-1 immunoreactivity was detected throughout the retinal capillaries of transgenic mice receiving zinc and increased significantly (P <0.001) after 20 to 49 weeks of ZnSO4 administration compared with age-matched transgenic control mice. At 20 and 49 weeks, retinal capillaries of transgenic mice that received zinc showed significantly thickened BMs compared with control animals (P <0.001). Moreover, wholemounts of the retinal vasculature from PAI-1 transgenic mice demonstrated an increased endothelial cell-to-pericyte ratio. CONCLUSIONS. PAI-1 overexpression in retinal microvasculature leads to retinal disease similar to that observed in diabetic retinopathy.

Original languageEnglish (US)
Pages (from-to)2296-2302
Number of pages7
JournalInvestigative Ophthalmology and Visual Science
Volume41
Issue number8
StatePublished - 2000
Externally publishedYes

Fingerprint

Plasminogen Activator Inhibitor 1
Microvessels
Transgenic Mice
Pericytes
Zinc
Endothelial Cells
Gold Colloid
Retinal Diseases
Metallothionein
Diabetic Retinopathy
Diabetes Complications
Basement Membrane
Microscopy
Electron Microscopy
Immunohistochemistry
Light
Antigens
Water

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Grant, M. B., Spoerri, P. E., Player, D. W., Bush, D. M., Ellis, E. A., Caballero, S., & Robison, W. G. (2000). Plasminogen activator inhibitor (PAI)-1 overexpression in retinal microvessels of PAI-1 transgenic mice. Investigative Ophthalmology and Visual Science, 41(8), 2296-2302.

Plasminogen activator inhibitor (PAI)-1 overexpression in retinal microvessels of PAI-1 transgenic mice. / Grant, Maria B.; Spoerri, Polyxenie E.; Player, Denifield W.; Bush, David M.; Ellis, E. Ann; Caballero, Sergio; Robison, W. Gerald.

In: Investigative Ophthalmology and Visual Science, Vol. 41, No. 8, 2000, p. 2296-2302.

Research output: Contribution to journalArticle

Grant, MB, Spoerri, PE, Player, DW, Bush, DM, Ellis, EA, Caballero, S & Robison, WG 2000, 'Plasminogen activator inhibitor (PAI)-1 overexpression in retinal microvessels of PAI-1 transgenic mice', Investigative Ophthalmology and Visual Science, vol. 41, no. 8, pp. 2296-2302.
Grant, Maria B. ; Spoerri, Polyxenie E. ; Player, Denifield W. ; Bush, David M. ; Ellis, E. Ann ; Caballero, Sergio ; Robison, W. Gerald. / Plasminogen activator inhibitor (PAI)-1 overexpression in retinal microvessels of PAI-1 transgenic mice. In: Investigative Ophthalmology and Visual Science. 2000 ; Vol. 41, No. 8. pp. 2296-2302.
@article{f15aca5806564f7cac1661cdd47b9c44,
title = "Plasminogen activator inhibitor (PAI)-1 overexpression in retinal microvessels of PAI-1 transgenic mice",
abstract = "PURPOSE. Previous studies have suggested that disturbances in plasminogen activator inhibitor (PAI)-1 may be relevant to the development of diabetic microvascular complications. To determine whether overexpression of PAI-1 in cells of retinal microvasculature would result in a disease similar to that observed in diabetes, ocular tissue from transgenic mice that overexpress human PAI-1 were examined. METHODS. Transgenic mice were administered ZnSO4 (25 mM) in their water for up to 49 weeks to activate the metallothionein promoter and stimulate human PAI-1. Colloidal gold immunocytochemistry was used to quantify the human PAI-1 antigen at 7, 20, 34, and 49 weeks of ZnSO4 administration. Cross sections of retinal microvessels were examined by electron microscopy for changes in basement membrane (BM) thickness. Retinal digest preparations were examined by light microscopy for possible microangiopathy, including changes in endothelial cell-to-pericyte ratios. RESULTS. Human PAI-1 immunoreactivity was detected throughout the retinal capillaries of transgenic mice receiving zinc and increased significantly (P <0.001) after 20 to 49 weeks of ZnSO4 administration compared with age-matched transgenic control mice. At 20 and 49 weeks, retinal capillaries of transgenic mice that received zinc showed significantly thickened BMs compared with control animals (P <0.001). Moreover, wholemounts of the retinal vasculature from PAI-1 transgenic mice demonstrated an increased endothelial cell-to-pericyte ratio. CONCLUSIONS. PAI-1 overexpression in retinal microvasculature leads to retinal disease similar to that observed in diabetic retinopathy.",
author = "Grant, {Maria B.} and Spoerri, {Polyxenie E.} and Player, {Denifield W.} and Bush, {David M.} and Ellis, {E. Ann} and Sergio Caballero and Robison, {W. Gerald}",
year = "2000",
language = "English (US)",
volume = "41",
pages = "2296--2302",
journal = "Investigative Ophthalmology and Visual Science",
issn = "0146-0404",
publisher = "Association for Research in Vision and Ophthalmology Inc.",
number = "8",

}

TY - JOUR

T1 - Plasminogen activator inhibitor (PAI)-1 overexpression in retinal microvessels of PAI-1 transgenic mice

AU - Grant, Maria B.

AU - Spoerri, Polyxenie E.

AU - Player, Denifield W.

AU - Bush, David M.

AU - Ellis, E. Ann

AU - Caballero, Sergio

AU - Robison, W. Gerald

PY - 2000

Y1 - 2000

N2 - PURPOSE. Previous studies have suggested that disturbances in plasminogen activator inhibitor (PAI)-1 may be relevant to the development of diabetic microvascular complications. To determine whether overexpression of PAI-1 in cells of retinal microvasculature would result in a disease similar to that observed in diabetes, ocular tissue from transgenic mice that overexpress human PAI-1 were examined. METHODS. Transgenic mice were administered ZnSO4 (25 mM) in their water for up to 49 weeks to activate the metallothionein promoter and stimulate human PAI-1. Colloidal gold immunocytochemistry was used to quantify the human PAI-1 antigen at 7, 20, 34, and 49 weeks of ZnSO4 administration. Cross sections of retinal microvessels were examined by electron microscopy for changes in basement membrane (BM) thickness. Retinal digest preparations were examined by light microscopy for possible microangiopathy, including changes in endothelial cell-to-pericyte ratios. RESULTS. Human PAI-1 immunoreactivity was detected throughout the retinal capillaries of transgenic mice receiving zinc and increased significantly (P <0.001) after 20 to 49 weeks of ZnSO4 administration compared with age-matched transgenic control mice. At 20 and 49 weeks, retinal capillaries of transgenic mice that received zinc showed significantly thickened BMs compared with control animals (P <0.001). Moreover, wholemounts of the retinal vasculature from PAI-1 transgenic mice demonstrated an increased endothelial cell-to-pericyte ratio. CONCLUSIONS. PAI-1 overexpression in retinal microvasculature leads to retinal disease similar to that observed in diabetic retinopathy.

AB - PURPOSE. Previous studies have suggested that disturbances in plasminogen activator inhibitor (PAI)-1 may be relevant to the development of diabetic microvascular complications. To determine whether overexpression of PAI-1 in cells of retinal microvasculature would result in a disease similar to that observed in diabetes, ocular tissue from transgenic mice that overexpress human PAI-1 were examined. METHODS. Transgenic mice were administered ZnSO4 (25 mM) in their water for up to 49 weeks to activate the metallothionein promoter and stimulate human PAI-1. Colloidal gold immunocytochemistry was used to quantify the human PAI-1 antigen at 7, 20, 34, and 49 weeks of ZnSO4 administration. Cross sections of retinal microvessels were examined by electron microscopy for changes in basement membrane (BM) thickness. Retinal digest preparations were examined by light microscopy for possible microangiopathy, including changes in endothelial cell-to-pericyte ratios. RESULTS. Human PAI-1 immunoreactivity was detected throughout the retinal capillaries of transgenic mice receiving zinc and increased significantly (P <0.001) after 20 to 49 weeks of ZnSO4 administration compared with age-matched transgenic control mice. At 20 and 49 weeks, retinal capillaries of transgenic mice that received zinc showed significantly thickened BMs compared with control animals (P <0.001). Moreover, wholemounts of the retinal vasculature from PAI-1 transgenic mice demonstrated an increased endothelial cell-to-pericyte ratio. CONCLUSIONS. PAI-1 overexpression in retinal microvasculature leads to retinal disease similar to that observed in diabetic retinopathy.

UR - http://www.scopus.com/inward/record.url?scp=0033937497&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033937497&partnerID=8YFLogxK

M3 - Article

C2 - 10892876

AN - SCOPUS:0033937497

VL - 41

SP - 2296

EP - 2302

JO - Investigative Ophthalmology and Visual Science

JF - Investigative Ophthalmology and Visual Science

SN - 0146-0404

IS - 8

ER -